J. R. Mali et al. / Tetrahedron Letters 50 (2009) 5025–5027
5027
8. Witt, A.; Bergman, J. Curr. Org. Chem. 2003, 7, 659. and references cited therein.
9. Patel, N. B.; Patel, V. N. Iranian J. Pharma. Res. 2007, 6, 251.
10. Kumar, A.; Rajput, C. S.; Bhati, S. K. Bioorg. Med. Chem. 2007, 15, 3089.
11. Holmes, C. P.; Chinn, J. P.; Look, G. C.; Gordon, E. M.; Gallop, M. A. J. Org. Chem.
1995, 60, 7328.
pressure. The residue was obtained and added to ice-cold water.
The solid that was obtained was filtered, washed with water, and
crystallized from ethanol–DMF.
Yield: 90%, mp: 230–231 °C.
12. Srivastava, S. K.; Srivastava, S. L.; Srivastava, S. D. J. Ind. Chem. Soc. 2000, 77,
104.
3.5. Synthesis of N-(2-(4-methoxyphenyl)-4-oxothiazolidin-3-
yl)-2-(4-oxoquinazolin-3-(4H)–yl) acetamide (6b quinazolinyl
4-thiazolidinone)
13. Sharma, R. C.; Kumar, D. J. J. Ind. Chem. Soc. 2000, 77, 492.
14. Srivastava, T.; Haq, W.; Katti, S. B. Tetrahedron 2002, 58, 7619.
15. Gududuru, V.; Nguyen, V.; Dalton, J. T.; Miller, D. D. Synlett 2004, 2357.
16. Fraga-Dubreuil, J.; Bazureau, J. P. Tetrahedron 2003, 59, 6121.
17. Dandia, A.; Singh, R.; Khaturia, S.; Merienne, C.; Georges, M.; Loupy, A. Bioorg.
Med. Chem. 2006, 14, 2409.
18. Patel, K. H.; Mehta, A. G. E-J. Chem. 2006, 3, 103.
19. Firouzabadi, H.; Iranpoor, N.; Karimi, B.; Hazarkhani, H. Synth. Commun. 2003,
33, 3653.
20. Karade, H.; Sathe, M.; Kaushik, M. P. Molecules 2007, 12, 1341.
21. Karade, H.; Sathe, M.; Kaushik, M. P. Cat. Commun. 2007, 8, 741.
22. Heravi, M. M.; Zadmard, R.; Ghassemzadeh, M.; Tajbakhsh, M.; Riahifar, N.
Phosphorus, Sulfur Silicon 2001, 17, 687.
23. Das, B.; Reddy, M. R.; Holla, H.; Ramu, R.; Vekateswarlu, K.; Rao, Y. K. J. Chem.
Res. (S) 2005, 793.
24. Shirini, F.; Zolfigol, M. A.; Khaleghi, M. Phosphorus, Sulfur Silicon 2003, 178,
2107.
25. Srinivas, K. V. N. S.; Mahender, I.; Das, B. Synthesis 2003, 2479.
26. Firouzabadi, H.; Iranpoor, N.; Karimi, B.; Hazarkhani, H. Synlett 2000, 263.
27. Shirini, F.; Zolfigol, M. A.; Khaleghi, M.; Mohammadpour-Baltork, I. Synth.
Commun. 2003, 33, 1839.
A mixture of N0-(4-methoxybenzylidene)-2-(4-oxoquinazolin-
3-(4H)–yl) acetohydrazide 5b (0.1 mol), mercaptoacetic acid
(0.15 mol), and silica chloride (0.025 mol) was heated at 50 °C un-
der solvent-free condition for 1 h. The progress of the reaction was
monitored by TLC using hexane–ethyl acetate (7:3). After the com-
pletion of the reaction, the reaction mixture was extracted with
ethyl acetate and organic layer was washed with 5% sodium bicar-
bonate solution and brine. Organic layer was separated and dried
over anhydrous sodium sulfate. From the organic extract the sol-
vent was removed under reduced pressure and the residual crude
solid, thiazolidinone was crystallized from ethanol.
Yield: 93%, mp: 140–143 °C.
All the synthesized compounds were characterized by IR, 1H
NMR, and mass spectroscopic techniques.32
28. Srinivas, K. V. N. S.; Mahender, I.; Das, B. Chem. Lett. 2003, 32, 738.
29. Mohanazadeh, F.; Momeni, A. J. Sci. I.R. Iran 1996, 7, 261.
30. Hasaninejad, A.; Zare, A.; Sharghi, H.; Shekouhy, M.; Khalifeh, R.; Beni, A. S.;
Zare, A. R. M. Can. J. Chem. 2007, 85, 416.
31. (a) Pratap, U. R.; Mali, J. R.; Jawale, D. V.; Mane, R. A. Tetrahedron Lett. 2009, 50,
1352; (b) Mahalle, S. R.; Netankar, P. D.; Bondge, S. P.; Mane, R. A. Green Chem.
Lett. Rev. 2008, 2, 103.
4. Conclusion
The use of silica chloride to accelerate the rate of the cyclocon-
densation of azomethines and mercaptoacetic acid to obtain 4-
thiazolidinones under solvent-free condition has been reported
for the first time. The developed synthetic route is simple, eco-
friendly, and high yielding.
32. Spectral data for selected compounds: compound 2: IR (KBr, cmꢀ1): 1736,
1611. 1H NMR (400 MHz, DMSO-d6): dppm 3.02 (t, 3H), 4.22 (q, 2H), 4.74 (s, 2H),
7.58 (d, 1H, J = 8 HZ), 7.77 (m, 2H), 7.80 (s, 1H), 8.29 (d, 1H, J = 8 HZ). 13C NMR
(400 MHz, DMSO-d6): 14.68, 47.92, 62.00, 121.94, 126.69, 128.01, 135.36,
148.61, 160.81, 168.62. Mass: m/z 233 (M+). Compound 3: IR (KBr, cmꢀ1): 3153,
3051, 1683, 1607. 1H NMR (400 MHz, DMSO-d6): dppm 4.27 (s, 2H), 4.58 (s, 2H),
7.52 (t, 1H, J = 8 Hz), 7.67 (d, 1H, J = 8 Hz), 7.80 (t, 1H, J = 8 Hz), 8.10 (d, 1H,
J = 8 Hz), 8.21 (s, 1H), 9.40 (s, 1H). Mass: m/z 219 (M+). Compound 5b: IR (KBr,
cmꢀ1): 3294, 1682, 1607. 1H NMR (400 MHz, DMSO-d6): dppm 3.80 (s, 3H), 5.21
(s, 2H), 7.04 (d, 2H, J = 8 Hz), 7.5–7.8 (m, 4H), 8.1 (s, 1H), 8.2 (d, 2H, J = 8 Hz), 8.
40 (s, 1H), 11.68 (s, 1H). Mass: m/z 337 (M+). Compound 6a: IR (KBr, cmꢀ1):
Acknowledgment
The authors are thankful to Professor D. B. Ingle for his invalu-
able discussions and guidance.
3423, 1573 cmꢀ1 1H NMR (400 MHz, DMSO-d6): dppm 3.68 (s, 2H), 4.70 (s, 2H),
.
5.73 (s, 1H), 7.37–7.44 (m, 5H, Ar), 7.53 (t, 1H, J = 8 Hz), 7.67 (d, 1H, J = 8 Hz),
7.81 (t, 1H, J = 8 Hz), 8.25 (s, 1H), 8.11 (d, 1H, J = 8 Hz), 10.65 (s, 1H). Mass: m/z
381 (M+). Compound 6b: IR (KBr, cmꢀ1): 3188, 1678, 1608, 1519. 1H NMR
(400 MHz, DMSO-d6): dppm 3.70 (s, 2H), 4.68 (s, 2H), 5.69 (s, 1H), 6.94 (d, 2H,
J = 8 Hz), 7.31 (d, 2H, J = 8 Hz), 7.55 (t, 1H, J = 8 Hz), 7.67 (d, 1H, J = 8 Hz), 7.82
(t, 1H, J = 8 Hz), 8.11 (d, 1H, J = 8 Hz), 8.25 (s, 1H), 10.58 (s, 1H). Mass: m/z 411
(M+). Compound 6c: IR (KBr, cmꢀ1): 3344, 1735, 1676, 1611. 1H NMR
(400 MHz, DMSO-d6): dppm 2.28 (s, 3H), 3.70 (s, 2H), 4.57 (s, 2H), 5.85 (s,
1H), 7.15 (d, 2H, J = 8 Hz), 7.25 (d, 2H, J = 8 Hz), 7.52 (t, 1H, J = 8 Hz), 7.65 (d, 1H,
J = 8 Hz), 7.81 (t, 1H, J = 8 Hz), 8.09 (d, 1H, J = 8 Hz), 8.20 (s, 1H). Mass: m/z 395
(M+). Compound 6d: IR (KBr, cmꢀ1): 3221, 1681, 1611, 1511. 1H NMR
(400 MHz, DMSO-d6): dppm 3.71 (s, 2H), 4.69 (s, 2H), 5.77 (s, 1H), 7. 27 (t, 1H,
J = 8 Hz), 7.56 (d, 1H, J = 8 Hz), 7.71 (d, 1H, J = 8 Hz), 7.82 (d, 2H, J = 8 Hz), 7.86
(t, 1H, J = 8 Hz), 8.15 (d, 2H, J = 8 Hz), 8.27 (s, 1H), 10.67 (s, 1H). Mass: m/z 399
(M+).
References and notes
1. Cantello, B. C. C.; Cawthorne, M. A.; Cottam, G. P.; Duff, P. T.; Haigh, D.; Hindley,
R. M.; Lister, C. A.; Smith, S. A.; Thurlby, P. L. J. Med. Chem. 1994, 37, 3977.
2. Bhat, A. R.; Shetty, S. J. Ind. Pharm. Sci. 1987, 194.
3. Ragah, F. A.; Eid, N. M.; EI-Tawab, H. A. Pharmazie 1997, 52, 926.
4. Vigorita, M. G.; Ottana, R.; Monforte, F.; Maccari, R.; Trovato, A.; Monforte, M.
T.; Taviano, M. F. Bioorg. Med. Chem. Lett. 2001, 11, 2791.
5. Bhatt, J. J.; Shah, B. R.; Shah, H. P.; Trivedi, P. B.; Undavia, N. K.; Desai, N. C.
Indian J. Chem., Sect. B 1994, 33, 184.
6. Capan, G.; Ulusoy, N.; Ergenc, N.; Kiraz, M. Monatsh. Chem. 1999, 130, 1399.
7. Maskey, P. R.; Shaaban, M.; Grun-Wollny, I.; Laatsch, H. J. Nat. Prod. 2004, 67,
1131. and references cited therein.